Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Human γδ T lymphocytes induce robust NK cell–mediated antitumor cytotoxicity through CD137 engagementBlood, 2010-09, Vol.116 (10), p.1726-1733 [Peer Reviewed Journal]2010 American Society of Hematology ;2010 by The American Society of Hematology 2010 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2009-07-234211 ;PMID: 20519625Full text available |
|
2 |
Material Type: Article
|
CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansionBlood, 2021-06, Vol.137 (23), p.3225-3236 [Peer Reviewed Journal]2021 American Society of Hematology ;Copyright © 2021 American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020009482 ;PMID: 33827115Full text available |
|
3 |
Material Type: Article
|
IMMU-26. HEIGHTENED LEVELS OF CIRCULATING CELL-FREE DNA CONTRIBUTE TO PERIPHERAL IMMUNOSUPPRESSION DURING GBM PROGRESSIONNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii136-vii137 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.523Full text available |
|
4 |
Material Type: Article
|
IMMU-13. PROMOTER DEMETHYLATION OF NY-ESO-1 PRIMES GLIOBLASTOMA FOR IMMUNOTHERAPEUTIC TARGETINGNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii134 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.511Full text available |
|
5 |
Material Type: Article
|
IMMU-14. MENINGEAL PLASMA CELLS MOUNT AN IMMUNOLOGICAL DEFENSE AGAINST GLIOBLASTOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii134 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.512Full text available |
|
6 |
Material Type: Article
|
IMMU-17. LEVERAGING CORE EPIGENETIC PROGRAMMING OF IMMUNOSUPPRESSIVE MYELOID CELLS FOR THERAPEUTIC TARGETING OF GLIOBLASTOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii135 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.515Full text available |
|
7 |
Material Type: Article
|
IMMU-22. REPROGRAMMING OF MICROGLIA/MACROPHAGES IN GLIOBLASTOMA IMPROVES ANTI-TUMOR T CELL RESPONSESNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii136-vii136 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.520Full text available |
|
8 |
Material Type: Article
|
IMMU-41. VERSATILE MRNA-NANOPARTICLE PLATFORM TO REPROGRAM THE BRAIN TUMOR MICROENVIRONMENT AND PREDICT TREATMENT OUTCOMENeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii140 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.538Full text available |
|
9 |
Material Type: Article
|
IMMU-08. RAGE ABLATION ATTENUATES GLIOMA PROGRESSION AND ENHANCES TUMOR IMMUNE RESPONSES BY SUPPRESSING GALECTIN-3 EXPRESSIONNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii132-vii133 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.506Full text available |
|
10 |
Material Type: Article
|
IMMU-20. MODULATION OF THE PERIPHERAL T CELL BIOLOGY IN GLIOBLASTOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii135-vii135 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.518Full text available |
|
11 |
Material Type: Article
|
IMMU-05. THE INFLUENCE OF THE KETOGENIC DIET ON THE IMMUNE TOLERANT MICROENVIRONMENT IN GLIOBLASTOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii132-vii132 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.503Full text available |
|
12 |
Material Type: Article
|
IMMU-43. CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPYNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii141 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.540Full text available |
|
13 |
Material Type: Article
|
IMMU-16. SOMATIC MUTATIONS IN HUMAN LEUKOCYTE ANTIGEN GENES AND ANTIGEN PRESENTATION PATHWAY GENES IN MALIGNANT GLIOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii134 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.514Full text available |
|
14 |
Material Type: Article
|
IMMU-15. HUMAN ALLOGENIC γδ T CELLS KILL PATIENT-DERIVED GLIOBLASTOMA CELLS IN A PVR- AND DNAM-1-DEPENDENT MANNERNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii134 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.513Full text available |
|
15 |
Material Type: Article
|
IMMU-23. ELIMINATING MONOCYTE CHEMOATTRACTION INVOKES COMPENSATORY NEUTROPHIL INFLUX AND PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii136-vii136 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.521Full text available |
|
16 |
Material Type: Article
|
IMMU-09. IMMUNOLOGICAL CHARACTERIZATION OF PEDIATRIC BRAIN TUMORS HAS CLINICAL IMPLICATIONS FOR PATIENT MANAGEMENT AND PROGNOSISNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii133 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.507Full text available |
|
17 |
Material Type: Article
|
IMMU-42. ADOPTIVE HEMATOPOIETIC STEM CELL AND APD1 THERAPY CONVERGE IN THE THYMUS TO PROMOTE ANTI-GLIOBLASTOMA IMMUNITYNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii140 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.539Full text available |
|
18 |
Material Type: Article
|
IMMU-10. EXPLORING THE IMMUNOLOGIC CONSEQUENCES OF ATRX DEFICIENCY IN GLIOMANeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii133 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.508Full text available |
|
19 |
Material Type: Article
|
IMMU-40. KINETICS OF DEXAMETHASONE-INDUCED ALTERATIONS OF DIVERSE IMMUNE SUBSETS IN VIVONeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii140 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.537Full text available |
|
20 |
Material Type: Article
|
IMMU-11. NONO IS A NEW ADENOVIRUS SENSOR: IMPLICATION FOR VIROTHERAPYNeuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii133 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.509Full text available |